Global Viral Vector and Plasmid DNA Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Viral Vector and Plasmid DNA will have significant change from previous year. By the most conservative estimates of global Viral Vector and Plasmid DNA market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 547.3 million in 2020. Over the next five years the Viral Vector and Plasmid DNA market will register a 20.0% CAGR in terms of revenue, the global market size will reach US$ 1135.7 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector and Plasmid DNA market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Plasmid DNA
Viral Vector
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Virus Infection
Hereditary Disease
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
MolMed
FUJIFILM Diosynth Biotechnologies
UniQure
Aldevron
Richter-Helm
Eurogentec
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Vector and Plasmid DNA Market Size 2016-2026
2.1.2 Viral Vector and Plasmid DNA Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Viral Vector and Plasmid DNA Segment by Type
2.2.1 Plasmid DNA
2.2.2 Plasmid DNA
2.3 Viral Vector and Plasmid DNA Market Size by Type
2.3.1 Global Viral Vector and Plasmid DNA Market Size CAGR by Type
2.3.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
2.4 Viral Vector and Plasmid DNA Segment by Application
2.4.1 Cancer
2.4.2 Virus Infection
2.4.3 Hereditary Disease
2.5 Viral Vector and Plasmid DNA Market Size by Application
2.5.1 Global Viral Vector and Plasmid DNA Market Size CAGR by Application
2.5.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
3 Viral Vector and Plasmid DNA Market Size by Players
3.1 Viral Vector and Plasmid DNA Market Size Market Share by Players
3.1.1 Global Viral Vector and Plasmid DNA Revenue by Players (2019-2021E)
3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2019-2021E)
3.2 Global Viral Vector and Plasmid DNA Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Viral Vector and Plasmid DNA by Regions
4.1 Viral Vector and Plasmid DNA Market Size by Regions (2016-2021)
4.2 Americas Viral Vector and Plasmid DNA Market Size Growth (2016-2021)
4.3 APAC Viral Vector and Plasmid DNA Market Size Growth (2016-2021)
4.4 Europe Viral Vector and Plasmid DNA Market Size Growth (2016-2021)
4.5 Middle East & Africa Viral Vector and Plasmid DNA Market Size Growth (2016-2021)
5 Americas
5.1 Americas Viral Vector and Plasmid DNA Market Size by Country (2016-2021)
5.2 Americas Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
5.3 Americas Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector and Plasmid DNA Market Size by Region (2016-2021)
6.2 APAC Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
6.3 APAC Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Vector and Plasmid DNA by Country (2016-2021)
7.2 Europe Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
7.3 Europe Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Vector and Plasmid DNA by Region (2016-2021)
8.2 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2016-2021)
8.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Viral Vector and Plasmid DNA Market Forecast
10.1 Global Viral Vector and Plasmid DNA Forecast by Regions (2021-2026)
10.1.1 Global Viral Vector and Plasmid DNA Forecast by Regions (2021-2026)
10.1.2 Americas Viral Vector and Plasmid DNA Forecast
10.1.3 APAC Viral Vector and Plasmid DNA Forecast
10.1.4 Europe Viral Vector and Plasmid DNA Forecast
10.1.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast
10.2 Americas Viral Vector and Plasmid DNA Forecast by Countries (2021-2026)
10.2.1 United States Viral Vector and Plasmid DNA Market Forecast
10.2.2 Canada Viral Vector and Plasmid DNA Market Forecast
10.2.3 Mexico Viral Vector and Plasmid DNA Market Forecast
10.2.4 Brazil Viral Vector and Plasmid DNA Market Forecast
10.3 APAC Viral Vector and Plasmid DNA Forecast by Region (2021-2026)
10.3.1 China Viral Vector and Plasmid DNA Market Forecast
10.3.2 Japan Viral Vector and Plasmid DNA Market Forecast
10.3.3 Korea Viral Vector and Plasmid DNA Market Forecast
10.3.4 Southeast Asia Viral Vector and Plasmid DNA Market Forecast
10.3.5 India Viral Vector and Plasmid DNA Market Forecast
10.3.6 Australia Viral Vector and Plasmid DNA Market Forecast
10.4 Europe Viral Vector and Plasmid DNA Forecast by Country (2021-2026)
10.4.1 Germany Viral Vector and Plasmid DNA Market Forecast
10.4.2 France Viral Vector and Plasmid DNA Market Forecast
10.4.3 UK Viral Vector and Plasmid DNA Market Forecast
10.4.4 Italy Viral Vector and Plasmid DNA Market Forecast
10.4.5 Russia Viral Vector and Plasmid DNA Market Forecast
10.5 Middle East & Africa Viral Vector and Plasmid DNA Forecast by Region (2021-2026)
10.5.1 Egypt Viral Vector and Plasmid DNA Market Forecast
10.5.2 South Africa Viral Vector and Plasmid DNA Market Forecast
10.5.3 Israel Viral Vector and Plasmid DNA Market Forecast
10.5.4 Turkey Viral Vector and Plasmid DNA Market Forecast
10.5.5 GCC Countries Viral Vector and Plasmid DNA Market Forecast
10.6 Global Viral Vector and Plasmid DNA Forecast by Type (2021-2026)
10.7 Global Viral Vector and Plasmid DNA Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Brammer Bio
11.1.1 Brammer Bio Company Information
11.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Offered
11.1.3 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Brammer Bio Main Business Overview
11.1.5 Brammer Bio Latest Developments
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Information
11.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Oxford BioMedica Main Business Overview
11.2.5 Oxford BioMedica Latest Developments
11.3 Cobra Biologics
11.3.1 Cobra Biologics Company Information
11.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Offered
11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Cobra Biologics Main Business Overview
11.3.5 Cobra Biologics Latest Developments
11.4 FinVector
11.4.1 FinVector Company Information
11.4.2 FinVector Viral Vector and Plasmid DNA Product Offered
11.4.3 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 FinVector Main Business Overview
11.4.5 FinVector Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Viral Vector and Plasmid DNA Product Offered
11.5.3 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 BioReliance
11.6.1 BioReliance Company Information
11.6.2 BioReliance Viral Vector and Plasmid DNA Product Offered
11.6.3 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 BioReliance Main Business Overview
11.6.5 BioReliance Latest Developments
11.7 MolMed
11.7.1 MolMed Company Information
11.7.2 MolMed Viral Vector and Plasmid DNA Product Offered
11.7.3 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 MolMed Main Business Overview
11.7.5 MolMed Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 UniQure
11.9.1 UniQure Company Information
11.9.2 UniQure Viral Vector and Plasmid DNA Product Offered
11.9.3 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 UniQure Main Business Overview
11.9.5 UniQure Latest Developments
11.10 Aldevron
11.10.1 Aldevron Company Information
11.10.2 Aldevron Viral Vector and Plasmid DNA Product Offered
11.10.3 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Aldevron Main Business Overview
11.10.5 Aldevron Latest Developments
11. Richter-Helm
11.11.1 Richter-Helm Company Information
11.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Offered
11.11.3 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Richter-Helm Main Business Overview
11.11.5 Richter-Helm Latest Developments
11.12 Eurogentec
11.12.1 Eurogentec Company Information
11.12.2 Eurogentec Viral Vector and Plasmid DNA Product Offered
11.12.3 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Eurogentec Main Business Overview
11.12.5 Eurogentec Latest Developments
11.13 OBiO Technology
11.13.1 OBiO Technology Company Information
11.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Offered
11.13.3 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 OBiO Technology Main Business Overview
11.13.5 OBiO Technology Latest Developments
11.14 Yposkesi
11.14.1 Yposkesi Company Information
11.14.2 Yposkesi Viral Vector and Plasmid DNA Product Offered
11.14.3 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Yposkesi Main Business Overview
11.14.5 Yposkesi Latest Developments
11.15 Cell and Gene Therapy Catapult
11.15.1 Cell and Gene Therapy Catapult Company Information
11.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Offered
11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Cell and Gene Therapy Catapult Main Business Overview
11.15.5 Cell and Gene Therapy Catapult Latest Developments
11.16 MassBiologics
11.16.1 MassBiologics Company Information
11.16.2 MassBiologics Viral Vector and Plasmid DNA Product Offered
11.16.3 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 MassBiologics Main Business Overview
11.16.5 MassBiologics Latest Developments
11.17 Biovian
11.17.1 Biovian Company Information
11.17.2 Biovian Viral Vector and Plasmid DNA Product Offered
11.17.3 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Biovian Main Business Overview
11.17.5 Biovian Latest Developments
11.18 VGXI
11.18.1 VGXI Company Information
11.18.2 VGXI Viral Vector and Plasmid DNA Product Offered
11.18.3 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 VGXI Main Business Overview
11.18.5 VGXI Latest Developments
11.19 Gene Synthesis
11.19.1 Gene Synthesis Company Information
11.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Offered
11.19.3 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Gene Synthesis Main Business Overview
11.19.5 Gene Synthesis Latest Developments
11.20 PlasmidFactory
11.20.1 PlasmidFactory Company Information
11.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Offered
11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 PlasmidFactory Main Business Overview
11.20.5 PlasmidFactory Latest Developments
11.21 Jikai Gene
11.21.1 Jikai Gene Company Information
11.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Offered
11.21.3 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Jikai Gene Main Business Overview
11.21.5 Jikai Gene Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Viral Vector and Plasmid DNA Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Plasmid DNA
Table 3. Major Players of Viral Vector
Table 4. Viral Vector and Plasmid DNA Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Viral Vector and Plasmid DNA Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
Table 7. Viral Vector and Plasmid DNA Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Viral Vector and Plasmid DNA Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
Table 10. Global Viral Vector and Plasmid DNA Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2019-2021E)
Table 12. Viral Vector and Plasmid DNA Key Players Head office and Products Offered
Table 13. Viral Vector and Plasmid DNA Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Vector and Plasmid DNA Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Viral Vector and Plasmid DNA Market Size Market Share by Regions 2016-2021
Table 18. Americas Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Viral Vector and Plasmid DNA Market Size Market Share by Country (2016-2021)
Table 20. Americas Viral Vector and Plasmid DNA Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
Table 22. Americas Viral Vector and Plasmid DNA Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
Table 24. APAC Viral Vector and Plasmid DNA Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Viral Vector and Plasmid DNA Market Size Market Share by Region (2016-2021)
Table 26. APAC Viral Vector and Plasmid DNA Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
Table 28. APAC Viral Vector and Plasmid DNA Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
Table 30. Europe Viral Vector and Plasmid DNA Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country (2016-2021)
Table 32. Europe Viral Vector and Plasmid DNA Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
Table 34. Europe Viral Vector and Plasmid DNA Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Viral Vector and Plasmid DNA
Table 43. Key Application and Potential Industries of Viral Vector and Plasmid DNA
Table 44. Key Challenges of Viral Vector and Plasmid DNA
Table 45. Key Trends of Viral Vector and Plasmid DNA
Table 46. Global Viral Vector and Plasmid DNA Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Viral Vector and Plasmid DNA Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Viral Vector and Plasmid DNA Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Viral Vector and Plasmid DNA Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Viral Vector and Plasmid DNA Market Size Market Share Forecast by Application (2021-2026)
Table 52. Brammer Bio Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 53. Brammer Bio Viral Vector and Plasmid DNA Product Offered
Table 54. Brammer Bio Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Brammer Bio Main Business
Table 56. Brammer Bio Latest Developments
Table 57. Oxford BioMedica Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 58. Oxford BioMedica Viral Vector and Plasmid DNA Product Offered
Table 59. Oxford BioMedica Main Business
Table 60. Oxford BioMedica Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Oxford BioMedica Latest Developments
Table 62. Cobra Biologics Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 63. Cobra Biologics Viral Vector and Plasmid DNA Product Offered
Table 64. Cobra Biologics Main Business
Table 65. Cobra Biologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Cobra Biologics Latest Developments
Table 67. FinVector Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 68. FinVector Viral Vector and Plasmid DNA Product Offered
Table 69. FinVector Main Business
Table 70. FinVector Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. FinVector Latest Developments
Table 72. Lonza Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 73. Lonza Viral Vector and Plasmid DNA Product Offered
Table 74. Lonza Main Business
Table 75. Lonza Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Lonza Latest Developments
Table 77. BioReliance Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 78. BioReliance Viral Vector and Plasmid DNA Product Offered
Table 79. BioReliance Main Business
Table 80. BioReliance Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. BioReliance Latest Developments
Table 82. MolMed Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 83. MolMed Viral Vector and Plasmid DNA Product Offered
Table 84. MolMed Main Business
Table 85. MolMed Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. MolMed Latest Developments
Table 87. FUJIFILM Diosynth Biotechnologies Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 88. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Offered
Table 89. FUJIFILM Diosynth Biotechnologies Main Business
Table 90. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 92. UniQure Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 93. UniQure Viral Vector and Plasmid DNA Product Offered
Table 94. UniQure Main Business
Table 95. UniQure Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. UniQure Latest Developments
Table 97. Aldevron Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 98. Aldevron Viral Vector and Plasmid DNA Product Offered
Table 99. Aldevron Main Business
Table 100. Aldevron Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Aldevron Latest Developments
Table 102. Richter-Helm Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 103. Richter-Helm Viral Vector and Plasmid DNA Product Offered
Table 104. Richter-Helm Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Richter-Helm Main Business
Table 106. Richter-Helm Latest Developments
Table 107. Eurogentec Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 108. Eurogentec Viral Vector and Plasmid DNA Product Offered
Table 109. Eurogentec Main Business
Table 110. Eurogentec Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Eurogentec Latest Developments
Table 112. OBiO Technology Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 113. OBiO Technology Viral Vector and Plasmid DNA Product Offered
Table 114. OBiO Technology Main Business
Table 115. OBiO Technology Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. OBiO Technology Latest Developments
Table 117. Yposkesi Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 118. Yposkesi Viral Vector and Plasmid DNA Product Offered
Table 119. Yposkesi Main Business
Table 120. Yposkesi Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Yposkesi Latest Developments
Table 122. Cell and Gene Therapy Catapult Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 123. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Offered
Table 124. Cell and Gene Therapy Catapult Main Business
Table 125. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Cell and Gene Therapy Catapult Latest Developments
Table 127. MassBiologics Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 128. MassBiologics Viral Vector and Plasmid DNA Product Offered
Table 129. MassBiologics Main Business
Table 130. MassBiologics Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. MassBiologics Latest Developments
Table 132. Biovian Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 133. Biovian Viral Vector and Plasmid DNA Product Offered
Table 134. Biovian Main Business
Table 135. Biovian Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Biovian Latest Developments
Table 137. VGXI Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 138. VGXI Viral Vector and Plasmid DNA Product Offered
Table 139. VGXI Main Business
Table 140. VGXI Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. VGXI Latest Developments
Table 142. Gene Synthesis Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 143. Gene Synthesis Viral Vector and Plasmid DNA Product Offered
Table 144. Gene Synthesis Main Business
Table 145. Gene Synthesis Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 146. Gene Synthesis Latest Developments
Table 147. PlasmidFactory Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 148. PlasmidFactory Viral Vector and Plasmid DNA Product Offered
Table 149. PlasmidFactory Main Business
Table 150. PlasmidFactory Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 151. PlasmidFactory Latest Developments
Table 152. Jikai Gene Details, Company Type, Viral Vector and Plasmid DNA Area Served and Its Competitors
Table 153. Jikai Gene Viral Vector and Plasmid DNA Product Offered
Table 154. Jikai Gene Viral Vector and Plasmid DNA Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 155. Jikai Gene Main Business
Table 156. Jikai Gene Latest Developments
List of Figures
Figure 1. Viral Vector and Plasmid DNA Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector and Plasmid DNA Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Viral Vector and Plasmid DNA Market Size Market Share by Type in 2020
Figure 7. Viral Vector and Plasmid DNA in Cancer
Figure 8. Global Viral Vector and Plasmid DNA Market: Cancer (2016-2021) & ($ Millions)
Figure 9. Viral Vector and Plasmid DNA in Virus Infection
Figure 10. Global Viral Vector and Plasmid DNA Market: Virus Infection (2016-2021) & ($ Millions)
Figure 11. Viral Vector and Plasmid DNA in Hereditary Disease
Figure 12. Global Viral Vector and Plasmid DNA Market: Hereditary Disease (2016-2021) & ($ Millions)
Figure 13. Global Viral Vector and Plasmid DNA Market Size Market Share by Application in 2020
Figure 14. Global Viral Vector and Plasmid DNA Revenue Market Share by Player in 2020
Figure 15. Global Viral Vector and Plasmid DNA Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Viral Vector and Plasmid DNA Market Size 2016-2021 ($ Millions)
Figure 17. APAC Viral Vector and Plasmid DNA Market Size 2016-2021 ($ Millions)
Figure 18. Europe Viral Vector and Plasmid DNA Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2016-2021 ($ Millions)
Figure 20. Americas Viral Vector and Plasmid DNA Market Size Market Share by Country in 2020
Figure 21. Americas Viral Vector and Plasmid DNA Market Size Market Share by Type in 2020
Figure 22. Americas Viral Vector and Plasmid DNA Market Size Market Share by Application in 2020
Figure 23. United States Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Viral Vector and Plasmid DNA Market Size Market Share by Regions in 2020
Figure 27. APAC Viral Vector and Plasmid DNA Market Size Market Share by Type in 2020
Figure 28. APAC Viral Vector and Plasmid DNA Market Size Market Share by Application in 2020
Figure 29. China Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Viral Vector and Plasmid DNA Market Size Market Share by Country in 2020
Figure 36. Europe Viral Vector and Plasmid DNA Market Size Market Share by Type in 2020
Figure 37. Europe Viral Vector and Plasmid DNA Market Size Market Share by Application in 2020
Figure 38. Germany Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Viral Vector and Plasmid DNA Market Size Market Share by Application in 2020
Figure 46. Egypt Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Viral Vector and Plasmid DNA Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 52. APAC Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 53. Europe Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 55. United States Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 56. Canada Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 59. China Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 60. Japan Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 61. Korea Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 63. India Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 64. Australia Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 65. Germany Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 66. France Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 67. UK Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 68. Italy Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 69. Russia Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 70. Spain Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 73. Israel Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Viral Vector and Plasmid DNA Market Size 2021-2026 ($ Millions)
